JP2015504921A5 - - Google Patents

Download PDF

Info

Publication number
JP2015504921A5
JP2015504921A5 JP2014554868A JP2014554868A JP2015504921A5 JP 2015504921 A5 JP2015504921 A5 JP 2015504921A5 JP 2014554868 A JP2014554868 A JP 2014554868A JP 2014554868 A JP2014554868 A JP 2014554868A JP 2015504921 A5 JP2015504921 A5 JP 2015504921A5
Authority
JP
Japan
Prior art keywords
hetre
use according
medicament
microbial infection
subject
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2014554868A
Other languages
English (en)
Japanese (ja)
Other versions
JP6557009B2 (ja
JP2015504921A (ja
Filing date
Publication date
Priority claimed from US13/478,990 external-priority patent/US20120264705A1/en
Application filed filed Critical
Publication of JP2015504921A publication Critical patent/JP2015504921A/ja
Publication of JP2015504921A5 publication Critical patent/JP2015504921A5/ja
Application granted granted Critical
Publication of JP6557009B2 publication Critical patent/JP6557009B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2014554868A 2012-01-26 2013-01-25 Dgla、15−ohepaおよび/または15−hetreを含む抗菌組成物およびそれらの使用方法 Expired - Fee Related JP6557009B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201261591036P 2012-01-26 2012-01-26
US61/591,036 2012-01-26
US13/478,990 US20120264705A1 (en) 2012-01-26 2012-05-23 Antimicrobial compositions comprising 15-hetre and methods of use thereof
US13/478,990 2012-05-23
PCT/US2013/023201 WO2013112876A1 (en) 2012-01-26 2013-01-25 Antimicrobial compositions comprising dgla, 15-ohepa and/or 15-hetre and methods of use thereof

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2017217054A Division JP2018065818A (ja) 2012-01-26 2017-11-10 Dgla、15−ohepaおよび/または15−hetreを含む抗菌組成物およびそれらの使用方法

Publications (3)

Publication Number Publication Date
JP2015504921A JP2015504921A (ja) 2015-02-16
JP2015504921A5 true JP2015504921A5 (cg-RX-API-DMAC7.html) 2016-03-10
JP6557009B2 JP6557009B2 (ja) 2019-08-07

Family

ID=47006834

Family Applications (3)

Application Number Title Priority Date Filing Date
JP2014554868A Expired - Fee Related JP6557009B2 (ja) 2012-01-26 2013-01-25 Dgla、15−ohepaおよび/または15−hetreを含む抗菌組成物およびそれらの使用方法
JP2017217054A Pending JP2018065818A (ja) 2012-01-26 2017-11-10 Dgla、15−ohepaおよび/または15−hetreを含む抗菌組成物およびそれらの使用方法
JP2019176350A Pending JP2020023513A (ja) 2012-01-26 2019-09-27 Dgla、15−ohepaおよび/または15−hetreを含む抗菌組成物およびそれらの使用方法

Family Applications After (2)

Application Number Title Priority Date Filing Date
JP2017217054A Pending JP2018065818A (ja) 2012-01-26 2017-11-10 Dgla、15−ohepaおよび/または15−hetreを含む抗菌組成物およびそれらの使用方法
JP2019176350A Pending JP2020023513A (ja) 2012-01-26 2019-09-27 Dgla、15−ohepaおよび/または15−hetreを含む抗菌組成物およびそれらの使用方法

Country Status (16)

Country Link
US (2) US20120264705A1 (cg-RX-API-DMAC7.html)
EP (1) EP2806868A4 (cg-RX-API-DMAC7.html)
JP (3) JP6557009B2 (cg-RX-API-DMAC7.html)
KR (1) KR20140117379A (cg-RX-API-DMAC7.html)
CN (1) CN104114166A (cg-RX-API-DMAC7.html)
AU (1) AU2013211982A1 (cg-RX-API-DMAC7.html)
BR (1) BR112014018421A8 (cg-RX-API-DMAC7.html)
CA (1) CA2857046A1 (cg-RX-API-DMAC7.html)
HK (1) HK1198921A1 (cg-RX-API-DMAC7.html)
IL (1) IL232777A0 (cg-RX-API-DMAC7.html)
MX (1) MX2014006947A (cg-RX-API-DMAC7.html)
PH (1) PH12014501693A1 (cg-RX-API-DMAC7.html)
RU (1) RU2014134720A (cg-RX-API-DMAC7.html)
SG (1) SG11201404088TA (cg-RX-API-DMAC7.html)
WO (1) WO2013112876A1 (cg-RX-API-DMAC7.html)
ZA (1) ZA201403948B (cg-RX-API-DMAC7.html)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0907413D0 (en) 2009-04-29 2009-06-10 Equateq Ltd Novel methods
US9855236B2 (en) 2011-10-19 2018-01-02 Ds Biopharma Limited Pharmaceutical compositions comprising DGLA and/or 15-HETrE and methods of use thereof
US8293790B2 (en) * 2011-10-19 2012-10-23 Dignity Sciences Limited Pharmaceutical compositions comprising DGLA and benzoyl peroxide and methods of use thereof
RU2014119948A (ru) * 2011-10-19 2015-11-27 Дигнити Сайенсиз Лимитед ФАРМАЦЕВТИЧЕСКИЕ КОМПОЗИЦИИ, СОДЕРЖАЩИЕ DGLA И/ИЛИ 15-HETrE, И СПОСОБЫ ИХ ПРИМЕНЕНИЯ
GB201301626D0 (en) 2013-01-30 2013-03-13 Dignity Sciences Ltd Composition comprising 15-OHEPA and methods of using the same
GB201307082D0 (en) * 2013-04-19 2013-05-29 Dignity Sciences Ltd Pharmaceutical composition comprising 15-HETrE and methods of using the same
WO2015042442A1 (en) * 2013-09-19 2015-03-26 Dignity Sciences Limited Pharmaceutical compositions comprising dha, epa, and/or gla and an antibiotic agent and methods of use thereof
ES2727387T3 (es) * 2013-11-15 2019-10-15 Ds Biopharma Ltd Sal de lisina de ácido 15-hidroxi-8(Z),11(Z),13(E)-eicosatrienoico
RU2685706C2 (ru) * 2014-01-10 2019-04-23 Эфиммьюн Лимитед Фармацевтические композиции, содержащие 15-гэпк, и способы лечения астмы и заболеваний легких с их применением
MX375328B (es) 2014-06-04 2025-03-06 Ds Biopharma Ltd Composiciones farmacéuticas que comprenden ácido dihomo-gamma-linolénico (dgla) y uso de las mismas
LT6177B (lt) 2014-10-10 2015-07-27 Uab "Biocentras" Fermentų kompleksų išskyrimas iš steptomyces gougerotii 101, daugiafermentinių biopreparatų ruošimas bei taikymas
MA41120A (fr) 2014-12-02 2017-10-10 Afimmune Ltd Compositions comprenant le 15-hepe et méthodes de traitement ou de prévention de la fibrose à l'aide de celles-ci
CN107405324A (zh) * 2015-01-16 2017-11-28 艾菲穆恩有限公司 包含15‑hepe的组合物和其使用方法
CN112245420A (zh) 2015-07-21 2021-01-22 艾菲穆恩有限公司 用于治疗或预防癌症和神经疾病的包括15-hepe的组合物
AU2016370626B2 (en) * 2015-12-18 2020-08-20 Afimmune Limited Compositions comprising 15-HEPE and methods of using the same
US20200206173A1 (en) 2017-08-30 2020-07-02 Conopco, Inc., D/B/A Unilever A personal care composition
US20210315851A1 (en) 2020-04-03 2021-10-14 Afimmune Limited Compositions comprising 15-hepe and methods of treating or preventing hematologic disorders, and/or related diseases

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4344930A (en) * 1975-10-30 1982-08-17 Colgate-Palmolive Company Skin care sponge
JP4926310B2 (ja) * 1996-02-15 2012-05-09 エルテーベー4・スウェーデン・アクチェボラーグ 抗ウイルス薬および抗腫瘍薬としてのロイコトリエンb4またはその類似体の使用
US5789441A (en) * 1996-02-15 1998-08-04 Virocell Inc. Leukotriene B4 as an antiviral and anti-neoplastic agent
US6190645B1 (en) * 1999-07-15 2001-02-20 Playtex Products, Inc. Sunscreen for the scalp hair and hair
US20030073930A1 (en) * 2001-10-17 2003-04-17 Morrissey Gerald R. Methods and device for preventing or healing injured nipples or areolas in mammalian females or for obtaining samples from nipples in mammalian females
US20030105445A1 (en) * 2001-11-30 2003-06-05 Kimberly-Clark Worldwide, Inc. Breast pad assembly containing a skin benefit ingredient
WO2005102309A2 (en) * 2004-04-26 2005-11-03 Ltb4 Sweden Ab In vivo release of endogenous anti-microbial mediators by leukotriene b4 (ltb4) administration
JP2009522303A (ja) * 2005-12-30 2009-06-11 ウェイ−ウー ヒー, 瘢痕を生じない皮膚創傷治癒を促進するsiRNA組成物および創傷処置の方法
JP2010509930A (ja) * 2006-11-23 2010-04-02 カーギル インコーポレイテッド 化工でんぷんの天然相当物
CN101715349B (zh) * 2007-05-08 2012-07-18 美国Rq生物科技有限公司 治疗革兰氏阴性细菌感染的治疗组合物及方法
EP2159732A1 (en) * 2008-08-21 2010-03-03 Thomson Licensing Method and device for code obfuscation
GB0907413D0 (en) * 2009-04-29 2009-06-10 Equateq Ltd Novel methods
US8637298B2 (en) * 2009-06-16 2014-01-28 E I Du Pont De Nemours And Company Optimized strains of yarrowia lipolytica for high eicosapentaenoic acid production
US8293790B2 (en) * 2011-10-19 2012-10-23 Dignity Sciences Limited Pharmaceutical compositions comprising DGLA and benzoyl peroxide and methods of use thereof

Similar Documents

Publication Publication Date Title
RU2014134720A (ru) Противомикробные композиции, содержащие dgla, 15-онера и/или 15-hetre, и способы их применения
SA520411571B1 (ar) مركبات كرومان مونوباكتام لعلاج العدوى البكتيرية
EP2328573B1 (en) Antibacterial combination therapy for the treatment of gram positive bacterial infections
JP2012522037A5 (cg-RX-API-DMAC7.html)
RU2010140682A (ru) Способ лечения пациента от инфекции, фармацевтическая композиция (варианты) и лекарственное средство
WO2012017349A3 (en) Topical pharmaceutical composition comprising nanonized silver sulfadiazine and chlorhexidine gluconate
JP2016507547A5 (cg-RX-API-DMAC7.html)
RU2015132369A (ru) Комбинированная терапия для лечения нозокомиальной пневмонии
FI3006038T3 (fi) Oritavansiinin yksittäisannokset bakteeri-infektion hoitoon tai ehkäisyyn
Gunjan et al. A comparative study of the effect of different topical agents on burn wound infections
JP2018500387A5 (cg-RX-API-DMAC7.html)
WO2020028561A1 (en) Bismuth-thiol compositions and methods for treating wounds
MX2023011616A (es) Compuestos de lactivicina, su preparacion y uso como agentes antibacterianos.
JP2008520660A5 (cg-RX-API-DMAC7.html)
NZ706734A (en) Pharmaceutical compositions useful for the treatment or control of bacterial infections
JP2024009968A5 (cg-RX-API-DMAC7.html)
JP5276653B2 (ja) カルバペネム類を含む殺菌性抗mrsa活性医薬組成物
JP2018521143A5 (cg-RX-API-DMAC7.html)
Alexpandi et al. Proteomic insights into the multi-target mechanism and therapeutic application of citronellol-loaded carboxymethyl chitosan-based hydrogel for wound infection treatment
JP6525999B2 (ja) 抗菌性組成物
JP2016510749A5 (cg-RX-API-DMAC7.html)
CN106794250A (zh) 包含抗菌剂的药物组合物
JP2016538262A (ja) 抗菌剤を含む医薬品組成物
JP2024547035A5 (cg-RX-API-DMAC7.html)
WO2009124086A3 (en) Antibacterial drug for treatment of staphylococcus aureus and other gram-positive bacterial infections